[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Genedx Holdings Corp (WGS)

Genedx Holdings Corp (WGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,543,479
  • Shares Outstanding, K 29,688
  • Annual Sales, $ 427,540 K
  • Annual Income, $ -21,020 K
  • EBIT $ -66 M
  • EBITDA $ -41 M
  • 60-Month Beta 2.06
  • Price/Sales 3.48
  • Price/Cash Flow 21.88
  • Price/Book 5.85

Options Overview Details

View History
  • Implied Volatility 75.36% (-0.82%)
  • Historical Volatility 207.66%
  • IV Percentile 49%
  • IV Rank 27.26%
  • IV High 133.95% on 10/23/25
  • IV Low 53.41% on 08/28/25
  • Expected Move (DTE 6) 1.28 (2.45%)
  • Put/Call Vol Ratio 0.23
  • Today's Volume 1,296
  • Volume Avg (30-Day) 3,088
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 22,087
  • Open Int (30-Day) 18,653
  • Expected Range 50.72 to 53.27

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.19
  • Number of Estimates 1
  • High Estimate $-0.19
  • Low Estimate $-0.19
  • Prior Year $0.50
  • Growth Rate Est. (year over year) -138.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.21 +61.41%
on 05/06/26
69.00 -24.65%
on 05/04/26
-10.91 (-17.34%)
since 04/29/26
3-Month
32.21 +61.41%
on 05/06/26
95.38 -45.49%
on 03/09/26
-27.72 (-34.78%)
since 02/27/26
52-Week
32.21 +61.41%
on 05/06/26
170.87 -69.57%
on 12/02/25
-18.03 (-25.75%)
since 05/28/25

Most Recent Stories

More News
GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS

SAN FRANCISCO , May 28, 2026 /PRNewswire/ -- Investors in GeneDx Holdings Corp. ( NASDAQ: WGS ) saw the price of their shares tank $33.42 (-49%) on May 5, 2025 after the company announced a...

WGS : 51.99 (+3.67%)
GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that company management will participate in the Goldman Sachs 47th Annual...

WGS : 51.99 (+3.67%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS

NEW YORK , May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp.  ("GeneDx" or the "Company") (NASDAQ: WGS).  Such investors are advised...

WGS : 51.99 (+3.67%)
GeneDx Holdings Corp. (WGS) Securities Fraud Investigation - Levi & Korsinsky

GeneDx posted Q1 2026 revenue of $102.3 million against consensus estimates near $110 million and reported adjusted EPS of -$0.28 versus the -$0.01 expected -- the stock collapsed approximately 44% in...

WGS : 51.99 (+3.67%)
Fraud Investigation Opened: Levi & Korsinsky Investigates GeneDx Holdings Corp. (WGS) on Behalf of Shareholders

New York, New York--(Newsfile Corp. - May 18, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into GeneDx Holdings Corp. (NASDAQ: WGS) ("GeneDx Holdings Corp.") concerning...

WGS : 51.99 (+3.67%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS

NEW YORK , May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp.  ("GeneDx" or the "Company") (NASDAQ: WGS).  Such investors are advised...

WGS : 51.99 (+3.67%)
WGS Investor Alert: Levi & Korsinsky Investigates GeneDx Holdings Corp. (WGS) for Potential Securities Fraud

GeneDx CFO promised quarterly profitability weeks before the company posted an $8.2 million adjusted loss -- and then cut full-year guidance by approximately 12%.

WGS : 51.99 (+3.67%)
Fraud Investigation Opened: Levi & Korsinsky Investigates GeneDx Holdings Corp. (WGS) on Behalf of Shareholders

New York, New York--(Newsfile Corp. - May 11, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ: WGS) concerning...

WGS : 51.99 (+3.67%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS

NEW YORK , May 7, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp.  ("GeneDx" or the "Company") (NASDAQ: WGS).  Such investors are advised...

WGS : 51.99 (+3.67%)
GeneDx Holdings Corp. (WGS) Under Investigation for Potential Securities Law Violations - Contact Levi & Korsinsky Today

New York, New York--(Newsfile Corp. - May 7, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ: WGS) concerning...

WGS : 51.99 (+3.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn.

See More

Key Turning Points

3rd Resistance Point 56.20
2nd Resistance Point 54.19
1st Resistance Point 53.09
Last Price 51.99
1st Support Level 49.98
2nd Support Level 47.97
3rd Support Level 46.87

See More

52-Week High 170.87
Fibonacci 61.8% 117.90
Fibonacci 50% 101.54
Fibonacci 38.2% 85.18
Last Price 51.99
52-Week Low 32.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.